---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-269451"
form_type: "8-K"
ticker: "CERS"
cik: "0001020214"
company_name: "CERUS CORP"
filed_at: "2025-11-06T23:59:59+00:00"
generated_at: "2026-05-16T23:19:12.847293+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cerus Q3 revenue up 19% to $60.2M, raises FY2025 product revenue guidance

## Summary
- Product revenue $52.7M (+15% YoY); total revenue $60.2M (+19% YoY).
- GAAP net loss narrowed to $0.02M (near breakeven); non-GAAP adjusted EBITDA $5.0M.
- U.S. IFC sales $3.9M, volumes up ~110% YoY; hospital demand increasing.
- Full-year 2025 product revenue guidance raised to $202-204M (prev. $200-203M).
- Cash and investments $78.5M; generated $1.9M operating cash flow in Q3.

## SEC filing metadata
- accession: 0001193125-25-269451
- form_type: 8-K
- ticker: CERS
- cik: 0001020214
- company_name: CERUS CORP
- filed_at: 2025-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1020214/000119312525269451/0001193125-25-269451-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1020214/000119312525269451/cers-20251106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-269451
- JSON: https://secwatch.observer/filing/0001193125-25-269451.json
- Plain text: https://secwatch.observer/filing/0001193125-25-269451.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.